LaBina PL-1000 Mobil, Руководство по эксплуатации

Страница: 10 / 36

10 EN PL-1000 Mobil
O
Self-tanning products
should be avoided by the customer in the first two to three days after the treatment.
Contraindications and side effects
The following contraindications and side effects are the results of a thorough analysis of the
professional clinical literature concerning micropigmentation. If the person responsible for
the treatment should have the smallest doubt that the safety of the customer being treated
cannot be guaranteed, for example due to secondary illnesses or conditions, the treatment
should be withheld or stopped immediately.
Contraindications
With the following contraindications, no permanent make-up treatment should be undertak-
en:
O
Haemophilia or other blood-clotting disorders
O
Currently taking blood thinning medication (e.g. Warfarin, Heparin, aspirin, acetylsalicylic
acid)
O
Uncontrolled diabetes mellitus
O
Any form of active acne in the area of the treatment
O
Dermatosis (e.g. Skin tumours, keloids or extreme tendency for keloid formation, solar
keratosis, warts and/or moles) in the area of the treatment
O
Open wounds and/or eczema and/or rashes in the area of the treatment
O
Scars in the treatment area
O
Systemic infections and infectious diseases (e.g. Hepatitis type A, B, C, D, E or F; HIV in-
fection) or acute local skin infections (e.g. herpes, rosacea)
O
During chemotherapy, radiotherapy or high-dosage corticosteroid therapy (recommenda-
tion: from four weeks before the start until four weeks after the end of the therapy)
O
Up to twelve months after a plastic surgery operation in the area to be treated
O
Up to six months after filler injections in the area to be treated
O
Allergy to topical anaesthetics (local anaesthetic)
O
Under the influence of alcohol and/or drugs
O
Pregnancy and lactation
The treatment of mucous membrane and eyeballs is strictly forbidden.
The treatment must be immediately aborted in the event of:
O
Excessive perception of pain
O
Fainting/dizziness
2.4
2.4.1